- Home
- BMY vs COP Comparison
BMY vs COP Comparison
Compare BMY & COP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMY | COP |
|---|---|---|
| Founded | 1887 | 1917 |
| Country | United States | United States |
| Employees | 32500 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.7B | 136.5B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | BMY | COP |
|---|---|---|
| Price | $59.78 | $121.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 20 |
| Target Price | $61.93 | ★ $116.80 |
| AVG Volume (30 Days) | ★ 9.8M | 8.7M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 4.26% | 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.35 |
| Revenue | N/A | ★ $58,944,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.46 |
| P/E Ratio | ★ $17.26 | $19.22 |
| Revenue Growth | N/A | ★ 7.67 |
| 52 Week Low | $42.52 | $79.88 |
| 52 Week High | $62.89 | $122.50 |
Technical Indicators
Market Signals| Indicator | BMY | COP |
|---|---|---|
| Relative Strength Index (RSI) | 50.26 | 68.76 |
| Support Level | $59.23 | $91.18 |
| Resistance Level | $62.47 | $122.50 |
| Average True Range (ATR) | 1.17 | 3.02 |
| MACD | -0.45 | 0.25 |
| Stochastic Oscillator | 31.86 | 92.56 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About COP ConocoPhillips
ConocoPhillips is a US-based independent exploration and production firm. Its operations are primarily in Alaska and the Lower 48, with footprints in Canada, Europe, Asia-Pacific, the Middle East, and Africa. It also has substantial integrated LNG production and marketing activities across geographies.